查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球蛋白質組學市場：規模/份額/趨勢分析（技術/試劑/軟件/服務/應用程序/最終用戶）、區域展望、競爭策略、分部預測（至 2030 年）
市場調查報告書
商品編碼
1076147

全球蛋白質組學市場：規模/份額/趨勢分析（技術/試劑/軟件/服務/應用程序/最終用戶）、區域展望、競爭策略、分部預測（至 2030 年）

Proteomics Market Size, Share & Trends Analysis By Technology, By Reagent, By Software & Service, By Application, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 240 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球蛋白質組學市場預計將以 15.2% 的複合年增長率增長，到 2030 年達到 925.5 億美元。市場的主要驅動力是傳染病的流行、癌症和遺傳疾病的發病率增加，以及對蛋白質和基因測序研究的需求不斷增長。

本報告分析了全球蛋白質組學市場，包括市場基本結構、主要影響因素、整體市場規模趨勢展望（2019-2030），按技術、試劑和軟件/我們正在按服務調查詳細趨勢、應用程序、最終用戶和地區、新型冠狀病毒感染 (COVID-19) 的影響以及主要公司的概況。

目錄

第 1 章介紹

第 2 章調查方法

第 3 章執行摘要

第 4 章市場動態

  • 促進因素、抑制因素、機會和問題分析
  • 新冠肺炎 (COVID-19)：對蛋白質組學市場的影響

第 5 章市場波動因素及前景

  • SWOT分析
  • PESTEL 分析
  • 波特五力分析
  • 熱圖分析

第 6 章全球蛋白質組學市場：按技術分類（單位：100 萬美元，2019-2030）

  • 光譜學
    • 質譜
    • 核磁共振波譜
    • CD光譜
  • 色譜法
    • 高效液相色譜
    • 離子色譜法
    • 親和層析
    • 超臨界流體色譜
  • 電泳
    • 凝膠電泳
    • 毛細管電泳
  • 蛋白質芯片
    • 生物芯片
    • 微陣列設備
  • X射線晶體結構分析
  • 表面等離子共振
  • 蛋白質組分

第 7 章全球蛋白質組學市場：按試劑（單位：100 萬美元，2019-2030）

  • 免疫分析試劑
  • 光譜試劑
  • 色譜試劑
  • 蛋白質芯片試劑
  • X射線晶體結構分析試劑
  • 電泳試劑
  • 蛋白質分離試劑

第 8 章全球蛋白質組學市場：按軟件/服務（單位：100 萬美元，2019-2030）

  • 核心蛋白質組學服務
    • 蛋白質鑑定服務
    • 蛋白質表征服務
    • 定量蛋白質組學服務
    • 蛋白質純化服務
    • 蛋白質測序服務
    • 定制化驗服務
  • 生物資訊學軟件服務
    • 生物資訊學軟件
    • 生物資訊學工具
    • 生物資訊學數據庫

第 9 章全球蛋白質組學市場：按用途分類（單位：100 萬美元，2019-2030）

  • 臨床診斷
    • 癌症
    • 傳染病
    • 糖尿病
    • 神經紊亂
    • 免疫疾病
    • 心血管疾病
    • 其他臨床診斷用途
  • 藥物發現
    • 目標發現
    • 線索識別
    • 讀取優化
    • 臨床前研究
  • 其他用途

第 10 章全球蛋白質組學市場：按最終用戶分類（單位：100 萬美元，2019-2030）

  • 醫院
  • 臨床研究所
  • 製藥公司
  • 學術研究
  • 其他最終用戶

第 11 章全球蛋白質組學市場：按地區劃分（單位：100 萬美元，2019-2030）

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 中東/非洲
    • 沙特阿拉伯王國
    • 阿拉伯聯合酋長國
    • 其他中東

第 12 章公司簡介

  • Agilent Technologies、Inc.
    • 公司簡介
    • 財務展望
    • 產品概覽
    • 近期趨勢
  • Applied Biomics, Inc.
  • Biognosys AG
  • Biomax Informatics AG
  • Bioproximity
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Creative Proteomics
  • Danaher Corporation
  • Eurofins Scientific
  • Fios Genomics Ltd.
  • GE Healthcare
  • GENEWIZ
  • HORIBA, Ltd.
  • Illumina, Inc.
  • Integrated Proteomics Applications
  • Luminex Corporation
  • Merck KGaA
  • MRM Proteomics Inc.
  • MS Bioworks LLC
  • PerkinElmer Inc.
  • Poochon Scientific, LLC
  • Promega Corporation
  • Proteome Factory AG
  • QIAGEN Bioinformatics
簡介目錄
Product Code: BIOT2225

The global proteomics market is projected to be worth USD 92.55 billion by 2030

According to SPER Market Research, the proteomics market is estimated to reach USD 92.55 billion by 2030 with a CAGR of 15.2%. The rising prevalence of infectious diseases has increased the demand for the study of proteins and gene sequencing. This study can help in developing novel treatments against viral diseases, cancer, and other genetic disorders.

Impact of COVID-19 on the proteomics Market

The COVID-19 pandemic has increased the focus on decoding 3d structures of SARS-CoV-2 proteins. In order to understand therapies against COVID-19, protein crystallization techniques have played a significant role to understand virus proteins and specific sites. This has impacted the proteomics market in positively and the marker has grown further.

Scope of the report:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030

Segments covered By Technology, By Reagents, By Software & Services, By Application, By End-User.

Geographies covered: North America, Europe, APAC, Latin America and the Middle East & Africa.

Companies Covered:

Agilent Technologies, Inc., Applied Biomics, Inc., Biognosys AG, Biomax Informatics AG, Bioproximity, Bio-Rad Laboratories, Inc., Bruker Corporation, Creative Proteomics, Danaher Corporation, Eurofins Scientific, Fios Genomics Ltd., GE Healthcare, GENEWIZ, HORIBA, Ltd., Illumina, Inc., Integrated Proteomics Applications, Luminex Corporation, Merck KGaA, MRM Proteomics Inc., MS Bioworks LLC, PerkinElmer Inc., Poochon Scientific, LLC, Promega Corporation, Proteome Factory AG, QIAGEN Bioinformatics

Driver: Rising incidence of cancer and genetic disorders

The incidence of cancer and geriatric disorders is rising creating an urgent need for better therapeutics. The recent discoveries around the sequencing of the human genome are helping in developing novel treatments by evaluating gene expression at the proteome level. The extraction of biological information in diseased patients can help in the development of novel treatments and thus can drive the proteomics market

Opportunity: Rising demand for nanoproteomics

Nanotechnology is gaining popularity in the plethora of applications in various industries. In proteomics, nanotechnology can be utilized to develop phosphoproteomics, nanostructured surfaces for protein separation, and detection techniques for biomarkers protein. The growth of nanoproteomics technology is providing growth opportunities to the proteomics market

Challenge: High cost of equipment

The research activities involved in proteomics & genomics involve highly expensive instruments and reagents. The cost of installation along with maintenance charges and indirect costs makes it very challenging for developing countries to adopt these technologies

Proteomics Market by Technology:

Based on technology, the market has been segmented into Spectroscopy (Mass Spectroscopy, NMR Spectroscopy, CD Spectroscopy), Chromatography (HPLC, Ion Chromatography, Affinity Chromatography, Supercritical Fluid Chromatography), Electrophoresis (Gel Electrophoresis, Capillary Electrophoresis), Protein Microarrays (Biochips [Lab-on-Chips, Protein Chips], Micrparray Instruments [Integrated Systems, Microarray Scanners, Arrayers]), X-Ray Crystallography, Surface Plasmon Resonance, Protein Fractionation

Proteomics Market by Reagents:

Based on reagents, the market is segmented into Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents, Protein Fractionation Reagents

Proteomics Market by Software & Services:

Based on software & services, the market is segmented into Core Proteomics Services (Protein Identification Services, Protein Characterization Services, Quantitative Proteomic Services, Protein Purification Services, Protein Sequencing Services, Custom Assay Services), Bioinformatics Software & Services (Bioinformatics Software, Bioinformatics Tools, Bioinformatics Databases)

Proteomics Market by Application:

Based on application, the market is segmented into Clinical Diagnostics (Cancer, Infectious Diseases, Diabetes, Neurological Disorders, Immune Diseases, Cardiovascular Diseases, and Other Clinical Diagnostic Applications), Drug Discovery (Target Discovery, Lead Identification, Lead Optimization, Preclinical Studies), Other Application

Proteomics Market by End User:

Based on end-users, the market is segmented into Hospitals, Clinical Laboratories, Pharmaceutical Companies, Academic Research Laboratories, and Other End Users.

Pharmaceutical & Biotechnological companies have the largest share of this market by the end-user due to rising public & private funding for proteomics & genomics research activities and rising outsourcing of research activities to CRO services associated with pharmaceutical companies

Proteomics Market by Region:

North America owns the largest share of this market owing to rising investments & funding, rising preference for high-quality research, focus on reproducibility in research, raising awareness for personalized medicines, and presence of leading players in this market

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary data
    • 2.1.2. Primary data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity, and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impact on the Proteomics Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL analysis
    • 5.2.1. Political landscape
    • 5.2.2. Economic landscape
    • 5.2.3. Social landscape
    • 5.2.4. Technological landscape
    • 5.2.5. Environmental landscape
    • 5.2.6. Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of Buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat map analysis

6. Global Proteomics Market, By Technology, 2019-2030 (USD Million)

  • 6.1. Spectroscopy
    • 6.1.1. Mass Spectroscopy
    • 6.1.2. NMR Spectroscopy
    • 6.1.3. CD Spectroscopy
  • 6.2. Chromatography
    • 6.2.1. HPLC
    • 6.2.2. Ion Chromatography
    • 6.2.3. Affinity Chromatography
    • 6.2.4. Supercritical Fluid Chromatography
  • 6.3. Electrophoresis
    • 6.3.1. Gel Electrophoresis
    • 6.3.2. Capillary Electrophoresis
  • 6.4. Protein Microarrays
    • 6.4.1. Biochips
      • 6.4.1.1. Lab-on-Chips
      • 6.4.1.2. Protein Chips
    • 6.4.2. Micrparray Instruments
      • 6.4.2.1. Integrated Systems
      • 6.4.2.2. Microarray Scanners
      • 6.4.2.3. Arrayers
  • 6.5. X-Ray Crystallography
  • 6.6. Surface Plasmon Resonance
  • 6.7. Protein Fractionation

7. Global Proteomics Market, By Reagents, 2019-2030 (USD Million)

  • 7.1. Immunoassay Reagents
  • 7.2. Spectroscopy Reagents
  • 7.3. Chromatography Reagents
  • 7.4. Protein Microarray Reagents
  • 7.5. X-Ray Crystallography Reagents
  • 7.6. Electrophoresis Reagents
  • 7.7. Protein Fractionation Reagents

8. Global Proteomics Market, By Software & Services, 2019-2030 (USD Million)

  • 8.1. Core Proteomics Services
    • 8.1.1. Protein Identification Services
    • 8.1.2. Protein Characterization Services
    • 8.1.3. Quantitative Proteomic Services
    • 8.1.4. Protein Purification Services
    • 8.1.5. Protein Sequencing Services
    • 8.1.6. Custom Assay Services
  • 8.2. Bioinformatics Software & Services
    • 8.2.1. Bioinformatics Software
    • 8.2.2. Bioinformatics Tools
    • 8.2.3. Bioinformatics Databases

9. Global Proteomics Market, By Application, 2019-2030 (USD Million)

  • 9.1. Clinical Diagnostics
    • 9.1.1. Cancer
    • 9.1.2. Infectious Diseases
    • 9.1.3. Diabetes
    • 9.1.4. Neurological Disorders
    • 9.1.5. Immune Diseases
    • 9.1.6. Cardiovascular Diseases
    • 9.1.7. Other Clinical Diagnostic Applications
  • 9.2. Drug Discovery
    • 9.2.1. Target Discovery
    • 9.2.2. Lead Identification
    • 9.2.3. Lead Optimization
    • 9.2.4. Preclinical Studies
  • 9.3. Other Application

10. Global Proteomics Market, By End User, 2019-2030 (USD Million)

  • 10.1. Hospitals
  • 10.2. Clinical Laboratories
  • 10.3. Pharmaceutical Companies
  • 10.4. Academic Research Laboratories
  • 10.5. Other End Users

11. Global Proteomics Market, By Region, 2019-2030 (USD Million)

  • 11.1. North America
    • 11.1.1. United States
    • 11.1.2. Canada
    • 11.1.3. Mexico
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. United Kingdom
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Australia
    • 11.3.5. South Korea
    • 11.3.6. Rest of Asia-Pacific
  • 11.4. South America
    • 11.4.1. Brazil
    • 11.4.2. Argentina
    • 11.4.3. Rest of South America
  • 11.5. Middle East & Africa
    • 11.5.1. Kingdom of Saudi Arabia
    • 11.5.2. United Arab Emirates
    • 11.5.3. Rest of Middle East & Africa

12. Company Profiles

  • 12.1. Agilent Technologies, Inc.
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2. Applied Biomics, Inc.
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3. Biognosys AG
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4. Biomax Informatics AG
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5. Bioproximity
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6. Bio-Rad Laboratories, Inc.
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7. Bruker Corporation
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8. Creative Proteomics
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9. Danaher Corporation
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary
    • 12.9.4. Recent developments
  • 12.10. Eurofins Scientific
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary
    • 12.10.4. Recent developments
  • 12.11. Fios Genomics Ltd.
    • 12.11.1. Company details
    • 12.11.2. Financial outlook
    • 12.11.3. Product summary
    • 12.11.4. Recent developments
  • 12.12. GE Healthcare
    • 12.12.1. Company details
    • 12.12.2. Financial outlook
    • 12.12.3. Product summary
    • 12.12.4. Recent developments
  • 12.13. GENEWIZ
    • 12.13.1. Company details
    • 12.13.2. Financial outlook
    • 12.13.3. Product summary
    • 12.13.4. Recent developments
  • 12.14. HORIBA, Ltd.
    • 12.14.1. Company details
    • 12.14.2. Financial outlook
    • 12.14.3. Product summary
    • 12.14.4. Recent developments
  • 12.15. Illumina, Inc.
    • 12.15.1. Company details
    • 12.15.2. Financial outlook
    • 12.15.3. Product summary
    • 12.15.4. Recent developments
  • 12.16. Integrated Proteomics Applications
    • 12.16.1. Company details
    • 12.16.2. Financial outlook
    • 12.16.3. Product summary
    • 12.16.4. Recent developments
  • 12.17. Luminex Corporation
    • 12.17.1. Company details
    • 12.17.2. Financial outlook
    • 12.17.3. Product summary
    • 12.17.4. Recent developments
  • 12.18. Merck KGaA
    • 12.18.1. Company details
    • 12.18.2. Financial outlook
    • 12.18.3. Product summary
    • 12.18.4. Recent developments
  • 12.19. MRM Proteomics Inc.
    • 12.19.1. Company details
    • 12.19.2. Financial outlook
    • 12.19.3. Product summary
    • 12.19.4. Recent developments
  • 12.20. MS Bioworks LLC
    • 12.20.1. Company details
    • 12.20.2. Financial outlook
    • 12.20.3. Product summary
    • 12.20.4. Recent developments
  • 12.21. PerkinElmer Inc.
    • 12.21.1. Company details
    • 12.21.2. Financial outlook
    • 12.21.3. Product summary
    • 12.21.4. Recent developments
  • 12.22. Poochon Scientific, LLC
    • 12.22.1. Company details
    • 12.22.2. Financial outlook
    • 12.22.3. Product summary
    • 12.22.4. Recent developments
  • 12.23. Promega Corporation
    • 12.23.1. Company details
    • 12.23.2. Financial outlook
    • 12.23.3. Product summary
    • 12.23.4. Recent developments
  • 12.24. Proteome Factory AG
    • 12.24.1. Company details
    • 12.24.2. Financial outlook
    • 12.24.3. Product summary
    • 12.24.4. Recent developments
  • 12.25. QIAGEN Bioinformatics
    • 12.25.1. Company details
    • 12.25.2. Financial outlook
    • 12.25.3. Product summary
    • 12.25.4. Recent developments